We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJAQW
751
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
$137K ﹤0.01%
174,994
PACXW
752
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$136K ﹤0.01%
83,330
CYXTW
753
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$136K ﹤0.01%
66,664
CBAH.WS
754
DELISTED
CBRE Acquisition Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A co
CBAH.WS
$136K ﹤0.01%
124,996
ACKIW
755
DELISTED
Ackrell SPAC Partners I Co Warrants
ACKIW
$134K ﹤0.01%
212,690
+50,196
+31% +$28.6K
DAL icon
756
PUT
Delta Air Lines
DAL
$60.1B
$132K ﹤0.01%
+20,000
New +$926K
XRX icon
757
PUT
Xerox
XRX
$425M
$132K ﹤0.01%
+30,600
New +$740K
TLGA.WS
758
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$132K ﹤0.01%
166,660
M icon
759
PUT
Macy's
M
$6.68B
$131K ﹤0.01%
+36,500
New +$648K
PV.WS
760
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$130K ﹤0.01%
124,996
KWAC.WS
761
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$129K ﹤0.01%
187,493
ADEX.WS
762
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$128K ﹤0.01%
187,493
ANAC.WS
763
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$128K ﹤0.01%
+125,098
New +$107K
NGL icon
764
PUT
NGL Energy Partners
NGL
$2.11B
$126K ﹤0.01%
+148,700
New +$333K
DISAW
765
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$126K ﹤0.01%
+139,711
New +$134K
SRZNW icon
766
Surrozen Inc Warrant
SRZNW
$8.86K
$125K ﹤0.01%
83,330
+54
+0.1% +$59
THCPU
767
DELISTED
Thunder Bridge Capital Partners IV, Inc. Unit
THCPU
$125K ﹤0.01%
+12,634
New +$125K
NAVI icon
768
PUT
Navient
NAVI
$853M
$124K ﹤0.01%
+191,500
New +$3.29M
ADT icon
769
PUT
ADT
ADT
$5.58B
$122K ﹤0.01%
+56,800
New +$571K
CXAIW icon
770
CXApp Inc Warrant
CXAIW
$955K
$122K ﹤0.01%
149,994
EUSGW
771
DELISTED
European Sustainable Growth Acquisition Corp. Warrant
EUSGW
$122K ﹤0.01%
124,996
PEARW
772
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$120K ﹤0.01%
83,330
SABSW icon
773
SAB Biotherapeutics Warrant
SABSW
$104K
$116K ﹤0.01%
124,996
EACPW
774
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$116K ﹤0.01%
174,994
FCAX.WS
775
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$116K ﹤0.01%
99,996

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.